The country's two top panels on Covid vaccination will get cracking in the coming week. They will be making key recommendations which will help the government firm up crucial decisions -- which vaccine is to be administered to children above 15; which vaccine will be the booster dose; and what will be the gap between the last dose and the 'precautionary' dose for the elderly.
For children, the toss-up is essentially between Covaxin and Zydus Cadila, though two more vaccinations are lined up. Till now, the understanding is that both will be used, a media report said. The data on trials in the 12+ age group and the 15 to 18 eligible criteria is, however, still not in public domain and has to be reviewed by experts.
Continue reading your story on the app
Continue reading your story in the newspaper
I will definitely be around IPL next year, says AB de Villiers
De Villiers had been a big part of RCB family before he retired from all forms of cricket last year.
SRK charms fans with his signature pose
Bollywood superstar Shah Rukh Khan never misses an opportunity to charm his fans and a latest video is a proof of the same.
Willing to meet Putin to end war, says Zelenskyy
Ukrainian President Volodymyr Zelenskyy said on Monday that President Vladimir Putin was the only Russian official he was willing to meet with to discuss how to end the war, as per reports by the Reuters.
LIC to declare Jan-Mar, FY22 results on May 30
It is informed that a meeting of the Board of Directors of the Corporation is scheduled to be held on May 30, 2022, LIC said in a regulatory filing on Tuesday.
Further FX reserve slump may cause alarm: IFA Global
India's foreign exchange reserves stood at $593.28 bln as on May 13, down around $49 bln from the peak in October.
May strike after meeting with Centre: Petrol dealers
Demands include reimbursement of money lost due to reduced taxes and an increase in commission
SRA declaration waived, schemes on fast-track
Slumdwellers and developers are expected to save at least three months of legal and procedural formalities; will stop the delay in sanctioning slum rehab projects, says state housing minister
Addressing Bhiwandi's 'elephant' in the room
The administration has taken a fortnightly drive in Bhiwandi, a hotbed of elephantiasis cases
China, Russia N-bombers cock a snook at summit
Chinese and Russian strategic bombers flew over the Sea of Japan as US President Joe Biden and PM Modi hobnobbed at a Quad summit in Tokyo.
MUMBAI HAADSON KA SHEHER
However, the death of over 5,000 people in road mishaps in just four months does not seem to be unduly worrying to traffic authorities.
बच्चों के लिए कोरोनारोधी दो टीकों को मंजूरी
औषधि महानियंत्रक का फैसला
6 साल के बच्चों के टीके को आपात मंजूरी
जायकोव-डी को 12 साल से अधिक उम्र के बच्चों को लगाने की मंजूरी मिली
Covaxin cleared for 6-12 age group, Corbevax for 5 to 12-year-olds
70% people who took booster dose didn't get Covid during 3rd wave in India, says study
Expert panel backs use of Corbevax in 5+ age group
An expert committee advising India's drugs regulator has recommended Biological E-made coronavirus vaccine Corbevax be approved for emergency use in children aged five and above, officials said on Thursday, making it the second shot to be backed for use in the under-12 age group although a final decision will need to be taken by the regulator and then the government.
A first in 716 days: Daily Covid cases below 1,000
Consistently Declining For Over 10 Weeks
Bharat Biotech's Booster Shots
Ella siblings Raches and Jalachari, who played a key role in development of Covaxin, now plan to take Bharat Biotech into newage products and therapies to beat chronic diseases such as cancer.
Bharat Biotech: Temporarily slowing down production of Covaxin
Bharat Biotech on Friday said it is temporarily slowing down production of its COVID-19 vaccine Covaxin across its manufacturing units for facility optimisation as it has already completed its supply obligations to procurement agencies and foresees decrease in demand.
Expert panel recommends granting nod to Serum's Covovax for 12-17 yr-olds
AN EXPERT PANEL of the country's central drug authority has recommended granting emergency use authorisation (EUA) to Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, official sources said on Friday.
Corbevax gets nod for 12-18-yr group
BIOLOGICAL E, A Hyderabad-based vaccine manufacturer, on Monday received emergency use authorisation (EUA) from India's drug regulator for their Covid-19 vaccine for the 12 to 18-year age group.
Dr Reddy's all set to launch Sputnik Light as booster dose
DR REDDY'S LABORATORIES said it was looking at introducing the Sputnik Light Covid-19 vaccine as a booster dose in the country.